top glp-1 drugs Comparing Ozempic, Wegovy and Other Part 3 will be about
Description
No intermediate observations between baseline and week 104 were used in the analysis 59
Korner, M., Stockli, M., Waser, B
Pratley, MD, can be reached at [email protected]
& Meier, J
This systematic review of low-to-moderate evidence on the GLP-1 user risk of perioperative regurgitation and aspiration will examine the ongoing challenges in developing evidence-based clinical guidelines for patients using GLP-1 RAs, particularly with respect to perioperative management
